Last reviewed · How we verify
NCT03907943
Assessment of Cognitive Function in Patients Undergoing Elective Carotid Endarterectomy
NA trial testing carotid endarterectomy in Cognitive Impairment in 150 participants. Status unknown.
31 March 2022
Quick facts
| Lead sponsor | Semmelweis University Heart and Vascular Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 150 |
| Start date | 4 March 2019 |
| Primary completion | 31 March 2022 |
| Estimated completion | 31 August 2022 |
| Sites | 1 location across Hungary |
Drugs / interventions tested
- carotid endarterectomy
Conditions studied
- Cognitive Impairment — all drugs for Cognitive Impairment →
Sponsor
Semmelweis University Heart and Vascular Center
Who can join
18 and older, any sex, with Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Assessment of cognitive function in patients undergoing elective carotid endarterectomy Classical treatment for ICA stenosis is carotid endarterectomy (CEA), which has been proven effective in preventing future stroke as well as improving cerebral perfusion. However, the influence of CEA on cognition is less defined, it remains unclear whether CEA can improve cognitive function. A change in cognition is one of the most threatening diseases of recent years, cognitive impairment significantly impacts patients, families, and healthcare system. The difference in the cognitive outcome may be accounted for microembolic events and adverse changes in haemodynamic circumstances. The aim of our study is to identify those factors what may have role in the postoperative cognitive decline. The study was approved by the Ethical Committee of the university ( SE RKEB: 17/2019) and written informed consent will be obtained from all patients. The investigators intend to enroll patient aged more than 18 years undergoing elective carotid endarterectomy at our hospital ( Semmelweis University Heart and Vascular Center). Exclusion criterion included young age (less than 18 years), incapacity and urgent surgery. The investigators would like to register at least 100-150 patients in our study. Most relevant anamnestic dates, the results of the laboratory and radiological reports will be recorded. Cognitive functions will be assessed one day before, one day and six month after the surgery using MMSE and a questionnaire called Frailty to characterize beside cognitive function the physiological reserve of the patients too. The investigators manage patients undergoing carotid endarterectomy with general anaesthesia, using inhaled or total intravenous agents. During the operation the investigators record beside the routine monitoring (intraarterial blood pressure, ECG, oxygen saturation, EtCO2, MAC) the cerebral tissue oxygen saturation using a near-infrared cerebral oximeter (Invos Cerebral/Somatic Oximeter) and the activity of the brain using GE Entropy Module. The investigators would like to register the changes in the haemodynamic and cerebral condition and compare these results against the clinical outcome and the changes of the questionnaires. Statistical analyses will be performed using Statistical Package for the Social Sciences.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Cerebrovascular dysregulation and postoperative cognitive alterations after carotid endarterectomy.
Sándor ÁD, Czinege Z, Szabó A, Losoncz E, et al · · 2024 · cited 4× · PMID 38877342 · DOI 10.1007/s11357-024-01237-6 -
Association of Diabetes with Greater Mid-Term Cognitive Decline After Carotid Surgery.
Sándor ÁD, Sikos PM, Varinot G, Kallinikos F, et al · · 2025 · cited 1× · PMID 41007750 · DOI 10.3390/biomedicines13092188
Verify or expand the search:
- PubMed search for NCT03907943
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of carotid endarterectomy
Trials testing the same drug.
- NCT07054060 — Endarterectomy Versus Stenting in Patients With Symptomatic Severe Carotid Stenosis - 2 · NA · recruiting
- NCT07083986 — Carotid Endarterectomy Versus Stenting in Patients With Acute Stage of Ischemic Stroke. · NA · enrolling by invitation
- NCT06175715 — General Versus Regional Anesthesia for Carotid Endarterectomy at Acute Ischemic Stroke Trial · NA · recruiting
- NCT04847752 — Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis · recruiting
- NCT04257942 — Pathological Crystallization of Cholesterol in Atherosclerosis · unknown
Other recruiting trials for Cognitive Impairment
Currently open trials in the same condition.
- NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
- NCT07396779 — Cognitive Task-Based Walking Effects on Cognition, Mood, Sleep, and Quality of Life in Older Adults With Brain Fog · NA · active not recruiting
- NCT07084831 — A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment i · Phase 3 · recruiting
- NCT07125378 — Living Independence Through Functional Training · Phase 1, PHASE2 · recruiting
- NCT07268079 — Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality · recruiting
Other Semmelweis University Heart and Vascular Center trials
Trials by the same sponsor.
- NCT07434193 — Biventricular or Left Bundle Branch Pacing to Assess the Effect of Cardiac Resynchronization Therapy in Patients Undergo · NA · recruiting
- NCT07296965 — Oral Microbiome in Carotid Atherosclerosis · recruiting
- NCT06501313 — PhotobiomoduLation for pAtientS With Advanced hEart failuRe · NA · not yet recruiting
- NCT05838937 — The Usefulness of Myocardial Work IndeX in ExtraCorporeal Membrane Oxygenation Patients · not yet recruiting
- NCT06173089 — REmote MOnitoring of paTiEnts witH pacEmaker or implAntable cardioverteR defibrillaTor · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03907943 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Semmelweis University Heart and Vascular Center
- Last refreshed: 11 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03907943.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing